Iqvia Financial News
23.10 / 11:43
Manufacturing
Pfizer
MAT
Iqvia
infection
Lupin gets USFDA nod to market generic antifungal tablets
Lupin Ltd on Monday said it has received approval from the US health regulator to market its generic Fluconazole tablets used in the treatment of fungal infections. The approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in strengths of 50 mg, 100 mg, 150 mg and 200 mg, Lupin said in a regulatory filing.
30.09 / 12:53
WhatsApp
Iqvia
reports
patient
medicines
Granules India gets USFDA nod for hypertension generic drug
Granules India on September 30 announced that it received a nod from the United States Food and Drug Administration (USFDA) for its new drug that is a generic equivalent of a listed drug used in the treatment of hypertension. The American medicine regulatory body has “approved the Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets USP, 50 mg/12.5 mg, 100 mg/12.5 mg, and 100 mg/25 mg", the Pune-headquartered drugmaker said in a release.
29.09 / 20:23
12.08 / 11:33
COST
UPS
Reuters
Progressive
Biogen
Iqvia
show
NOT
What happens when a $2 million gene therapy is not enough
By Deena Beasley
02.08 / 09:39
Manufacturing
MAT
Iqvia
Lupin gets USFDA nod to market generic skin treatment medication
Lupin on Wednesday said its American subsidiary has received an approval from the US health regulator to market a generic product used for treatment of skin issues. New Jersey-based Novel Laboratories Inc has received the approval from the US Food and Drug Administration (USFDA) for Fluocinolone Acetonide Topical Oil, Lupin said in a statement.
30.07 / 19:37
Citi
Lowe's
Waters
Action
Metro
Iqvia
Top drugmakers bet on trade generics to grow beyond metros
Trade generics is seeing a lot of action in recent times with the entry of large domestic pharmaceutical companies, who want to expand beyond metros and other top cities where they see potential growth in years to come. Trade generics are branded medicines that are not promoted to physicians but are directly sold through retailers and distributors. In India, trade generics have a market share of 20% by volume and 5-6% by value, according to data and analytics firm IQVIA.
25.07 / 08:43
Manufacturing
Iqvia
Aurobindo Pharma arm gets USFDA nod for Plerixafor injection
Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialities has received a final approval from the US health regulator for its generic version of Plerixafor injection indicated for patients with certain types of cancer to prepare them for stem cell transplant. The approval granted by the US Food & Drug Administration (USFDA) is to manufacture and market Plerixafor Injection of strengths 24 mg/1.2 mL (20 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing.
25.07 / 04:43
Platform
MAT
Iqvia
show
Pharma growth shrinks to 4.5% in June as Covid-led segments show decrease in sales
IPM) contracted for the first time in several months, reporting a lower growth of 4.5% in the month of June. As Covid cases continue to recede steeply, anti-infectives and respiratory segments also reported a de-growth, pulling the monthly growth down for June, according to data analytics platform IQVIA report. The Moving Annual Turnover (MAT) growth declined to 10.6% for the month of June from 11.3% in May.
frequently asked questions about Iqvia
What is Iqvia and why is it gaining attention?
Iqvia is a trending topic that is in the spotlight. On our site, we regularly publish updates related to this subject.
Where can I find the latest updates on Iqvia?
All latest articles about Iqvia can be found in the dedicated section. We publish information regularly.
How can I verify the accuracy of information on Iqvia?
We rely on trusted sources to ensure that the information about Iqvia is well-supported and informative for our readers.
